{"id":32398,"date":"2016-12-03T19:48:11","date_gmt":"2016-12-04T03:48:11","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/12\/research-sets-new-target-for-brain-cancer-therapy"},"modified":"2017-04-24T19:14:27","modified_gmt":"2017-04-25T02:14:27","slug":"research-sets-new-target-for-brain-cancer-therapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/12\/research-sets-new-target-for-brain-cancer-therapy","title":{"rendered":"Research sets new target for brain cancer therapy"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/research-sets-new-target-for-brain-cancer-therapy.jpg\"><\/a><\/p>\n<p>Great.<\/p>\n<hr>\n<p>Research published in Acta Neuropathologica, identified alterations in a protein known as ATRX in human brain tumours; researchers might also be able to target microRNAs directly, altering their levels to make cancer cells less likely to form tumours.<\/p>\n<p>A recent study suggests that two recently discovered genetic differences between brain cancer cells and normal tissue cells could offer clues to tumour behaviour and potential new targets for therapy.<\/p>\n<p>Published in Acta Neuropathologica, the study identified alterations in a protein known as ATRX in human brain tumours that arise as part of a genetically inherited condition known as neurofibromatosis type 1 (NF1). The disorder, marked initially by benign tumours on nerves, often leads to brain cancer, and although most NF1-related malignancies are nonaggressive, a fraction are \u201chigh-grade\u201d and difficult to treat, experts say.<\/p>\n<p><!-- Link: <a href=\"http:\/\/www.dnaindia.com\/health\/report-new-study-in-brain-cancer-sets-potential-targets-for-therapy-2279317\">http:\/\/www.dnaindia.com\/health\/report-new-study-in-brain-can...py-2279317<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Great. Research published in Acta Neuropathologica, identified alterations in a protein known as ATRX in human brain tumours; researchers might also be able to target microRNAs directly, altering their levels to make cancer cells less likely to form tumours. A recent study suggests that two recently discovered genetic differences between brain cancer cells and normal [\u2026]<\/p>\n","protected":false},"author":395,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,47],"tags":[],"class_list":["post-32398","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/395"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=32398"}],"version-history":[{"count":2,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32398\/revisions"}],"predecessor-version":[{"id":49512,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32398\/revisions\/49512"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=32398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=32398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=32398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}